Bone mineral density in patients with recently diagnosed, active rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 66, Issue 11, 2007, Pages 1508-1512

  Guler Yuksel M ^a   Bijsterbosch, J ^a   Goekoop Ruiterman, Y P M ^a   De Vries Bouwstra, J K ^b   Ronday, H K ^c   Peeters, A J ^d   De Jonge Bok, J M ^e   Breedveld, F C ^a   Dijkmans, B A C ^b,f   Allaart, C F ^a   Lems, W F ^b,f  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HAGA HOSPITAL   (Netherlands)

^d REINIER DE GRAAF HOSPITAL   (Netherlands)

^e GROENE HART HOSPITAL   (Netherlands)

^f JAN VAN BREEMEN INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; VITAMIN D;

ADULT; ARTICLE; BODY MASS; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HORMONE SUBSTITUTION; HUMAN; JOINT INJURY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OSTEOPOROSIS; POSTMENOPAUSE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS;

ADULT; AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; BODY MASS INDEX; BONE DENSITY; DENSITOMETRY, X-RAY; FEMALE; HIP JOINT; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOPOROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; RHEUMATOID FACTOR; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS;

EID: 35649001540     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2007.070839     Document Type: Article

References (41)

1. Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 1996;35:309-22.
2. Westhovens R, Dequeker J. Rheumatoid arthritis and osteoporosis. Z Rheumatol 2000;59(suppl 1):33-8.
3. Green MJ, Deodhar AA. Bone changes in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 2001;15:105-23.
4. Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995;54:49-52.
5. Huusko TM, Korpela M, Karppi P, Avikainen V, Kautiainen H, Sulkava R. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland. Ann Rheum Dis 2001;60:521-2.
6. Van Staa TP, Geusens P, Bijlsma JWJ, Leufkens HGM, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum 2006;54:3104-12.
7. Spector TD, Hall GM, McCloskey EV, Kanis JA. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ 1993;306:558.
8. Peel NF, Moore DJ, Barrington NA, Bax DE, Eastell R. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis. Ann Rheum Dis 1995;54:801-6.
9. Sambrook PN. The skeleton in rheumatoid arthritis: common mechanisms for bone erosion and osteoporosis? J Rheumatol 2000;27:2541-2.
10. Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, et al. Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheum 2000;43:250-8.
11. Takayanagi H, Iizuka H, Juji T, Nakagawa T, Yamamoto A, Miyazaki T, et al. Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis. Arthritis Rheum 2000;43:259-69.
12. Hofbauer LC, Khosla S, Dunstan CR, Lacey DL, Boyle WJ, Riggs BL. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 2000;15:2-12.
13. Geusens PP, LAndewe RBM, Garnero P, Chen D, Dunstan CR, Lems WF, Stinissen P, van der Heijde DMFM, van der Linden S, Boers M. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 2006;54:1772-7.
14. Sinigaglia L, Nervetti A, Mela Q, Bianchi G, Del Puente A, Di Munno O, et al. A multicenter cross sectional study on bone mineral density in rheumatoid arthritis. Italian Study Group on Bone Moss in Rheumatoid Arthritis. J Rheumatol 2000;27:2582-9.
15. Tengstrand B, Hafstrom I. Bone mineral density in men with rheumatoid arthritis is associated with erosive disease and sulfasalazine treatment but not with sex hormones. J Rheumatol 2002;29:2299-305.
16. Lodder MC, Haugeberg G, Lems WF, Uhlig T, Orstavik RE, Kostense PJ, et al. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum 2003;49:209-15.
17. Forsblad DH, Larsen A, Waltbrand E, Kvist G, Mellstrom D, Saxne T, et al. Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis. Ann Rheum Dis 2003;62:617-23.
18. Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, et al. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density. Ann Rheum Dis 2004;63:1576-80.
19. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 2000;43:522-30.
20. Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum 2000;43:2776-84.
21. Kroot EJ, Nieuwenhuizen MG, Waal Malefijt MC, van Riel PL, Pasker-de Jong PC, Laan RF. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum 2001;44:1254-60.
22. Haugeberg G, Orstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum 2002;46:1720-8.
23. Lems WF, Dijkmans BAC. Should we look for osteoporosis in patients with rheumatoid arthritis? Ann Rheum Dis 1998;57:325-7.
24. Laan RF, Buijs WC, Verbeek AL, Draad MP, Corstens FH, van de Putte LB, et al. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis 1993;52:21-6.
25. Shenstone BD, Mahmoud A, Woodward R, Elvins D, Palmer R, Ring F, et al. Bone mineral density in nonsteroid treated early rheumatoid arthritis. Ann Rheum Dis 1994;53:681-4.
26. Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet 1994;344:23-7.
27. Keller C, Hafstrom I, Svensson B. Bone mineral density in women and men with early rheumatoid arthritis. Scand J Rheumatol 2001;30:213-20.
28. Forslind K, Keller C, Svensson B, Hafstrom I. Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women. J Rheumatol 2003;30:2590-6.
29. Goekoop-Ruiterman YP, Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005;52:3381-90.
30. Kolta S, Ravaud P, Fechtenbaum M, Dougados M, Roux C. Accuracy and Precision of 62 densitometerd using a European Spine Phantom. Osteoporos Int 1999;10:14-19.
31. Tothill P, Hannan WJ, Wilkinson S. Comparisons between a pencil beam and two fan beam dual energy X-ray absorptiometers used for measuring total body bone and soft tissue. British Journal of Radiology 2001;74:166-76.
32. Jun Zhang MB, Kai F Yu. What's the Relative Risk? JAMA 1998;280:1690-91.
33. Versluis RGJA. Petri H, van de Ven CM, Scholtes ABJ, Papapoulos SE, Springer MP. Prevalentie van Osteoporose bij postmenopauzale vrouwen in een huisartspraktijk. Ned Tijdschr Geneeskd 1999;143:20-4.
34. Smeets-Goevaers CG, Lesusink GL, Papapoulos SE, Maartens LW, Keyzer JJ, Weerdenburg JP, Beijers LM, Zwinderman AH, Knottnerus JA, Pols HA, Pop VJ. The prevalence of low bone mineral density in Dutch perimenopausal women: the Eindhoven Perimenopausal Osteoporosis Study. Osteoporos Int 1998;8:404-9.
35. Als OS, Gotfredsen A, Riis BJ, Christiansen C. Are disease duration and degree of functional impairment determinants of bone loss in rheumatoid arthritis? Ann Rheum Dis 1985;44:406-11.
36. Egeland T, Munthe E. The role of the laboratory in rheumatology. Rheumatoid factors. Clin Rheum Dis 1983;9:135-60.
37. Jacoby RK, Jayson Ml, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11-year follow-up. Br Med J 1973;2:96-100.
38. Westedt ML, Herbrink P, Molenaar JL, de Vries E, Verlaan P, Stijnen T, et al. Rheumatoid factors in rheumatoid arthritis and vasculitis. Rheumatol Int 1985;5:209-14.
39. Vittecoq O, Pouplin S, Krzanowska K, Jouen-Beades F, Menard JF, Gayet A, Daragon A, Tron F, Le Loet X. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology 2003;8:939-46.
40. Van Zeben D, Hazes JM, Zwinderman AH, Cats A, van der Voort EA, Breedveld FC. Clinical significance of rheumatoid factors in early rheumatoid arthritis: results of a follow up study. Ann Rheum Dis 1992;9:1029-35.
41. Henderson LB, Adams JS, Goldstein DR, Braunstein GD, Rotter JI, Scheuner MT. A familial risk profile for osteoporosis. Genet Med 2000;2:222-5.